78 related articles for article (PubMed ID: 16086867)
1. [Correlation of HERG K+ channel protein expression to chemosensitivity of tumor cells to doxorubicin and its modulation by erythromycin].
Chen SZ; Jiang M; Zhen YS
Ai Zheng; 2005 Aug; 24(8):924-9. PubMed ID: 16086867
[TBL] [Abstract][Full Text] [Related]
2. HERG K+ channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin.
Chen SZ; Jiang M; Zhen YS
Cancer Chemother Pharmacol; 2005 Aug; 56(2):212-20. PubMed ID: 15812674
[TBL] [Abstract][Full Text] [Related]
3. [Lidamycin inhibits the proliferation of HERG K+ channel highly expressing cancer cells and shows synergy with anticancer drugs].
Shang BY; Shang Y; Zhen YS; Chen SZ
Yao Xue Xue Bao; 2011 Nov; 46(11):1321-5. PubMed ID: 22260022
[TBL] [Abstract][Full Text] [Related]
4. [Erythromycin inhibits the proliferation of HERG K+ channel highly expressing cancer cells and shows synergy with anticancer drugs].
Chen SZ; Zhang SH; Gong JH; Zhen YS
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(47):3353-7. PubMed ID: 17313833
[TBL] [Abstract][Full Text] [Related]
5. HERG K+ channel related chemosensitivity to sparfloxacin in colon cancer cells.
Gong JH; Liu XJ; Shang BY; Chen SZ; Zhen YS
Oncol Rep; 2010 Jun; 23(6):1747-56. PubMed ID: 20428834
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological separation of hEAG and hERG K+ channel function in the human mammary carcinoma cell line MCF-7.
Roy J; Vantol B; Cowley EA; Blay J; Linsdell P
Oncol Rep; 2008 Jun; 19(6):1511-6. PubMed ID: 18497958
[TBL] [Abstract][Full Text] [Related]
7. Human ether-à-go-go-related gene expression is essential for cisplatin to induce apoptosis in human gastric cancer.
Zhang R; Tian P; Chi Q; Wang J; Wang Y; Sun L; Liu Y; Tian S; Zhang Q
Oncol Rep; 2012 Feb; 27(2):433-40. PubMed ID: 22020779
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral expression of mature human neutrophil peptide-1 potentiates the therapeutic effect of doxorubicin in a mouse 4T1 breast cancer model.
Li D; Qin Q; Wang XY; Shi HS; Luo M; Guo FC; Wang W; Wang YS
Oncol Rep; 2014 Mar; 31(3):1287-95. PubMed ID: 24378474
[TBL] [Abstract][Full Text] [Related]
9. Erythromycin block of the HERG K+ channel: accessibility to F656 and Y652.
Duncan RS; Ridley JM; Dempsey CE; Leishman DJ; Leaney JL; Hancox JC; Witchel HJ
Biochem Biophys Res Commun; 2006 Mar; 341(2):500-6. PubMed ID: 16446155
[TBL] [Abstract][Full Text] [Related]
10. Effects of phosphodiesterase (PDE) inhibitors on human ether-a-go-go related gene (hERG) channel activity.
Yunomae K; Ichisaki S; Matsuo J; Nagayama S; Fukuzaki K; Nagata R; Kito G
J Appl Toxicol; 2007; 27(1):78-85. PubMed ID: 17146843
[TBL] [Abstract][Full Text] [Related]
11. Altering extracellular potassium concentration does not modulate drug block of human ether-a-go-go-related gene (hERG) channels.
Limberis JT; Su Z; Cox BF; Gintant GA; Martin RL
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1059-65. PubMed ID: 17042915
[TBL] [Abstract][Full Text] [Related]
12. Expression and significance of HERG (KCNH2) potassium channels in the regulation of MDA-MB-435S melanoma cell proliferation and migration.
Afrasiabi E; Hietamäki M; Viitanen T; Sukumaran P; Bergelin N; Törnquist K
Cell Signal; 2010 Jan; 22(1):57-64. PubMed ID: 19765650
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-134 modulates resistance to doxorubicin in human breast cancer cells by downregulating ABCC1.
Lu L; Ju F; Zhao H; Ma X
Biotechnol Lett; 2015 Dec; 37(12):2387-94. PubMed ID: 26318721
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
15. Blockade of HERG K+ channel by an antihistamine drug brompheniramine requires the channel binding within the S6 residue Y652 and F656.
Park SJ; Kim KS; Kim EJ
J Appl Toxicol; 2008 Mar; 28(2):104-11. PubMed ID: 17516459
[TBL] [Abstract][Full Text] [Related]
16. Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT.
Bridgland-Taylor MH; Hargreaves AC; Easter A; Orme A; Henthorn DC; Ding M; Davis AM; Small BG; Heapy CG; Abi-Gerges N; Persson F; Jacobson I; Sullivan M; Albertson N; Hammond TG; Sullivan E; Valentin JP; Pollard CE
J Pharmacol Toxicol Methods; 2006; 54(2):189-99. PubMed ID: 16563806
[TBL] [Abstract][Full Text] [Related]
17. Overexpression HERG K(+) channel gene mediates cell-growth signals on activation of oncoproteins SP1 and NF-kappaB and inactivation of tumor suppressor Nkx3.1.
Lin H; Xiao J; Luo X; Wang H; Gao H; Yang B; Wang Z
J Cell Physiol; 2007 Jul; 212(1):137-47. PubMed ID: 17311278
[TBL] [Abstract][Full Text] [Related]
18. [Functional expression of congenital long QT syndrome related HERG mutation A561V in vitro].
Li Y; Cui CC; Zhao YH; Xue XL; Zhang AF; Lian JF; Huang C
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Feb; 35(2):143-6. PubMed ID: 17445409
[TBL] [Abstract][Full Text] [Related]
19. Variability in the measurement of hERG potassium channel inhibition: effects of temperature and stimulus pattern.
Kirsch GE; Trepakova ES; Brimecombe JC; Sidach SS; Erickson HD; Kochan MC; Shyjka LM; Lacerda AE; Brown AM
J Pharmacol Toxicol Methods; 2004; 50(2):93-101. PubMed ID: 15385083
[TBL] [Abstract][Full Text] [Related]
20. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
